Abstract
Positron emission tomography (PET)/CT has become a widely used technology for preoperative staging of non-small cell lung cancer (NSCLC). Two recent randomized controlled trials (RCT) have established its efficacy over conventional staging, but no studies have assessed its cost-effectiveness. The objective of this study was to assess the cost-effectiveness of PET/CT as an adjunct to conventional workup for preoperative staging of NSCLC.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | European Journal of Nuclear Medicine and Molecular Imaging |
| Vol/bind | 38 |
| Udgave nummer | 5 |
| Sider (fra-til) | 802-9 |
| Antal sider | 8 |
| ISSN | 1619-7070 |
| DOI | |
| Status | Udgivet - 2011 |